GLUE/ 12/16/2025 · 6:42 AM Wells Fargo Upgrades GLUE, Jefferies Downgrades GBIO Wells Fargo upgrades Monte Rosa Therapeutics on 2026 catalysts, while Jefferies downgrades Generation Bio due to its pending acquisition by Xoma.
